Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant ...

LA JOLLA, CA - Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin® (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant ...

Holly Jordan's premature son survived — thanks to medical advances after Patrick Kennedy's death from Infant Respiratory Distress Syndrome decades earlier Holly Jordan, who works in business ...

The most likely diagnosis for this infant is bronchiolitis. This illness is the most common reason for hospitalization of an infant or preschool-age child in the United States. [1] Bronchiolitis is ...

A nine-month-old infant with severe respiratory complications was airlifted from Raipur to Hyderabad and treated at KIMS ...

Background: Extracorporeal membrane oxygenation (ECMO) has emerged as an advanced therapeutic option for managing acute respiratory distress syndrome (ARDS), especially severe cases of ARDS. However, ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed high lysolipid levels in those with acute respiratory distress syndrome (ARDS), which may ...

The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant ...